Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 10,499

Document Document Title
WO/2016/097750A1
A process for the production of lactic acid comprising: (a) reacting a stream rich in saccharide with sodium hydroxide in the presence of water to produce a reaction mixture comprising sodium lactate; and (b) subjecting at least part of ...  
WO/2016/098801A1
[Problem] To provide a method for preparing a highly active and highly durable catalyst in which the elution of catalytic metals is inhibited when carrying out liquid phase oxidation without using an alkali; and a method for manufacturin...  
WO/2016/092198A1
The invention relates to the use of haloapatites as a catalyst in the dehydration reaction of α-hydroxylated carboxylic acids or acid esters, in particular lactic acid or methyl lactate, as well as to a method for synthesizing unsaturat...  
WO/2016/092900A1
A method for producing a fluoropolyether that contains an acid fluoride and has a low molecular weight by decomposing a triflate or trifluoroacetate of a fluoropolyether having a hydroxyl group in the presence of a Lewis acid.  
WO/2016/090461A1
The present invention relates to crystalline 1-adamantanamine salts, and polymorphic forms thereof, of prostaglandin analog intermediates of formula 3a, 4a and 6a, useful in the preparation of Tafluprost and Lubiprostone and processes fo...  
WO/2016/088133A1
The invention relates to a process for the preparation of levulinic acid and more particularly to a selective conversion of fructose to levulinic acid in a mixture of glucose and fructose.  
WO/2016/087807A1
The invention relates to a process for the synthesis of a compound having the following formula (I), or a salt thereof, in which formula (I) R is a COOH, CH2OH or CHO group, comprising the step according to which but-3-ene-1,2-diol (BDO)...  
WO/2016/085317A1
The invention relates to a method for extracting ferulic acid and/or salts of same, from a previously conditioned source rich in ferulic acid and salts of same, comprising: adsorbing the ferulic acid and/or the salts thereof in a column ...  
WO/2016/078765A1
The present invention relates to methods for the production of enantiopure or enantioenriched Praziquantel precursors and to methods for the production of enantiopure or enantioenriched Praziquantel comprising the methods for the product...  
WO/2016/074068A1
Described herein are compounds of Formula I, or pharmaceutically acceptable salts thereof, or combinations thereof, as well as uses thereof. Such uses include promoting tissue self-repair or tissue regeneration of an organ, stimulating t...  
WO/2016/077832A2
The present disclosure provides a process for the preparation of compounds of formula (III), compounds of formula (V), and corresponding salts of formula (IV). The compounds made by the methods and processes of the invention are particul...  
WO/2016/075082A1
The present invention relates to processes comprising a combined racemization and stereoselective reductive amination step in which an aldehyde compound of formula (I) is contacted with an (R)-selective ω-transaminase or an (S)-selectiv...  
WO/2016/077832A3
The present disclosure provides a process for the preparation of compounds of formula (III), compounds of formula (V), and corresponding salts of formula (IV). The compounds made by the methods and processes of the invention are particul...  
WO/2016/070775A1
The present invention provides a comprehensive treatment method for a gulonic acid fermentation broth. Gulonic acid fermentation broth firstly is filtered through an organic membrane, then the obtained residue is filtered through a ceram...  
WO/2016/066584A1
The present invention refers to new solid forms of Enclomiphene citrate and Enclomiphene base, processes for preparing thereof and uses.  
WO/2016/063301A3
The present invention discloses anti-malarial compound of formula (I) Formula (I) wherein, X is selected from O or NH; R1, R2, R3, R4 and R5 is selected from H or OMe or CH3, -CH2-O-CH2- or -CH=CH-CH=CH-; Y is selected from O or NH and R...  
WO/2016/063286A1
A fluid composition comprises a triglyceride, having at least one alpha-branched fatty acid residue, wherein each alpha-branched fatty acid residue comprises at least one saturated or mono- unsaturated alkyl chain having a total number o...  
WO/2016/063301A4
The present invention discloses anti-malarial compound of formula (I) Formula (I) wherein, X is selected from O or NH; R1, R2, R3, R4 and R5 is selected from H or OMe or CH3, -CH2-O-CH2- or -CH=CH-CH=CH-; Y is selected from O or NH and R...  
WO/2016/063296A1
The present invention relates to the polyprenylated phloroglucinol compounds of formulae I and II. The present invention also provides synthesis and p-glycoprotein induction activity of the alkyl- and acyl- polyprenylated phloroglucinol ...  
WO/2016/058081A1
A solid form of Nilotinib hydrochloride, which exists as a co-crystal of nilotinib hydrochloride and levulinic acid having a molar ratio of nilotinib hydrochloride to levulinic acid of 1:2, and a process for the preparation of the co-cry...  
WO/2016/055819A1
The invention provides a new process for the preparation of treprostinil of formula (I) and its salts using several new intermediates during the building of the ringsystem.  
WO/2016/054726A1
The present invention concerns the use of compounds for preventing and/or treating diabetes, for modulating glucose, insulin, and/or triglyceride levels; for reducing blood glucose level; for maintaining or increasing insulin level; for ...  
WO/2016/054728A1
The present invention concerns the use of compounds for preventing and/or treating osteoporosis, for stimulating bone formation, for stimulating bone remodeling, for stimulating the differentiation and mineralization of osteoblasts, for ...  
WO/2016/054725A1
The present invention concerns the use of compounds for preventing and/or treating osteoporosis, for stimulating bone formation, for stimulating the differentiation and mineralization of osteoblasts, or for inhibiting bone resorption in ...  
WO/2016/042573A1
The present invention provides a process for preparation of {(2E,4E,6E,8E)-9-(4-methoxy-2,3,6- trimethyl)phenyl-3,7-dimethyl-nona-2,4,6,8}tetraenoate, an acitretin intermediate of formula (VI) with trans isomer ≥97%, comprising of reac...  
WO/2016/041351A1
The present invention relates to the technical field of organic chemistry, specifically an asymmetrical hydrogenation reaction of an α-ketonic acid compound, the scheme being as shown by formula (I), wherein R1 is a phenyl, a substitute...  
WO/2016/043264A1
A method for producing a vapor composition containing lactic acid, whereby: at vaporization, the formation of by-products such as acetaldehyde and carbon monoxide due to the heat decomposition of lactic acid and the like can be regulated...  
WO/2016/040223A1
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein-coupled receptor modulato...  
WO/2016/038033A1
The invention relates to a method for producing a compound of (IV), wherein R1 is an alkyl group having 1 - 4 carbon atoms, comprising the step of reacting cyclohexene with hydrogen peroxide and an alcohol R1OH in the presence of a catal...  
WO/2016/040225A1
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein-coupled receptor modulato...  
WO/2016/031803A1
[Problem] To provide a magnesium hydroxide-based solid solution which has smaller primary particles and secondary particles and improved reactivity with acid, when compared with conventional magnesium hydroxide (Mg(OH)2), improves the fl...  
WO/2016/023929A1
The invention discloses a method for the preparation of trifluoroacetylacetic acid in its dehydrated form with a low content of the hydrate of trifluoroacetoacetic acid.  
WO/2016/022943A2
Compounds derived from biomass, e.g., cellulose and lignins, methods of forming such compounds and polymers and products formed using such compounds.  
WO/2016/019579A1
Provided is a method for synthesizing an anti-inflammatory compound; and also provided is a method for preparing the intermediate compound of formula 2, which comprises contacting ethyl propiolate with lithium bromide in order to produce...  
WO/2016/020603A1
Process for producing a calix-[z]-arene in which: - a calix-[z]-arene in which R1=R2=R3=R4=X1=X2=X3=X4=H is supplied, - step (a): - this calix-[z]-arene is treated with an alkylating agent transmitting the R4 residue, so as to obtain a r...  
WO/2016/019868A1
Provided are a citric acid salt of a thiadiazole derivative DPP-IV inhibitor, and preparation method, pharmaceutical composition and use thereof for treating and/or preventing diseases benefiting from DPP-IV inhibition, particularly for ...  
WO/2016/012965A2
The present invention relates to substituted phenyl alkanoic acid compounds designated as the compound of Formula (I) (as described herein) or a tautomer, a stereoisomer, a geometrical isomer, a pharmaceutically acceptable salt, a pharma...  
WO/2016/012965A3
The present invention relates to substituted phenyl alkanoic acid compounds designated as the compound of Formula (I) (as described herein) or a tautomer, a stereoisomer, a geometrical isomer, a pharmaceutically acceptable salt, a pharma...  
WO/2016/013245A1
The purpose of the present invention is to provide: a catalyst material which is loaded with fine gold particles and has excellent catalytic activity; and a method for producing this catalyst material. A catalyst material according to th...  
WO/2016/010538A1
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the com...  
WO/2015/199729A1
The present invention provides tromethamine salt of (Z)-7-[3,5-Dihydroxy-2-((E)-3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-hept-5-enoic acid in crystalline Form 1 and amorphous form. This compound is may also be referred to as "tromet...  
WO/2015/188727A1
Disclosed is a new method for preparing an azetidinone compound represented by formula (I). The carboxylic ketoester represented by formula (II) serves as the raw material and is subjected to Grignard addition, stereoselective dehydratio...  
WO/2015/189244A1
The present invention relates to a method for the acetylation of an aqueous solution of lactic acid to (S)-2-acetyloxypropionic acid. The process comprises in particular removing water from the solution of lactic acid and reacting lactic...  
WO/2015/188005A1
The invention relates to the preparation and characterization of novel salts of (R)-isometheptene and crystalline forms thereof; moreover, the invention describes the use of the novel salts alone or in combination with other therapeutic ...  
WO/2015/186690A1
The present invention is useful for inhibiting decomposition of a glycan chain released in a β-elimination reaction of an O-linked glycan chain from glycoprotein by anhydrous hydrazine.  
WO/2015/183132A1
A salt of zinc or copper (II) which can be used as a biocide, having the general formula CH2=C(R1)COO-M-OCOR2(OH)m(COOH)n, where M is Zn or Cu, R1 is selected from the group including hydrogen and methyl, R2 is a substituted С1-С5 alky...  
WO/2015/181023A1
The method can be used for preparing a p-hydroxymandelic compound comprising at least a step of condensing at least one aromatic compound bearing at least one hydroxyl group and of which the para position is free, with glyoxylic acid, th...  
WO/2015/177179A1
A process to prepare a compound of Formula (I) wherein R3, R4 and R5 are each selected independently from hydrogen, halogen, alkyl, alkenyl, alkynyl, alkoxyl, and wherein the alkyl, alkenyl, alkynyl, and alkoxyl may be optionally substit...  
WO/2015/176153A1
The present application relates to amorfrutin analogs and uses as PPAR modulators for the treatment of metabolic syndrome, obesity, hyperlipidemia, elevated fasting blood glucose, elevated blood pressure, low HDL cholesterol, type 2 diab...  
WO/2015/172149A1
Core-shell particles and methods of making and using thereof are described herein. The core is formed of or contains one or more hydrophobic materials or more hydrophobic materials. The shell is formed of or contains hyperbranched polygl...  

Matches 101 - 150 out of 10,499